Timothy R Rebbeck Selected Research

Estrogen Receptors

12/2014	Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
4/2013	Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
4/2012	Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
1/2012	Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
10/2011	A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer.
1/2010	Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study.
2/2009	Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
3/2006	The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers.
1/2005	Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy R Rebbeck Research Topics

Disease

72	Neoplasms (Cancer) 05/2023 - 01/2002
44	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2002
41	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 10/2002
14	Ovarian Neoplasms (Ovarian Cancer) 08/2020 - 05/2002
12	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 09/2006
8	Carcinogenesis 01/2021 - 01/2002
6	Carcinoma (Carcinomatosis) 12/2021 - 05/2002
5	Obesity 01/2021 - 02/2011
5	Melanoma (Melanoma, Malignant) 06/2015 - 03/2002
4	Inflammation (Inflammations) 01/2022 - 09/2008
3	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2002
2	Paraproteinemias (Monoclonal Gammopathy) 01/2024 - 05/2022
2	COVID-19 01/2022 - 08/2021
2	Body Weight (Weight, Body) 10/2020 - 02/2011
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2017 - 02/2007
2	Disease Progression 09/2015 - 04/2015
2	Hot Flashes 06/2012 - 09/2010
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2011 - 09/2004
1	Anemia 12/2023
1	Morbid Obesity 05/2023
1	Hyperplasia 01/2023
1	Monoclonal Gammopathy of Undetermined Significance 05/2022
1	Hematologic Neoplasms (Hematological Malignancy) 05/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Multiple Myeloma 01/2022
1	Adenocarcinoma 07/2021
1	Margins of Excision 07/2021
1	Circulating Neoplastic Cells 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2002
10	Hormones (Hormone)IBA 05/2023 - 01/2002
9	Estrogen ReceptorsIBA 12/2014 - 01/2005
9	Estrogens (Estrogen)FDA Link 07/2013 - 01/2005
8	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2011
8	AndrogensIBA 12/2023 - 09/2008
8	DNA (Deoxyribonucleic Acid)IBA 08/2022 - 02/2002
8	Cytochrome P-450 CYP3AIBA 04/2013 - 11/2004
7	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 02/2008
6	ORALIT (ORS)IBA 01/2021 - 03/2006
6	Genetic Markers (Genetic Marker)IBA 01/2017 - 10/2002
5	EnzymesIBA 08/2014 - 08/2005
4	SteroidsIBA 06/2012 - 03/2006
3	NucleotidesIBA 06/2022 - 04/2015
3	GenieIBA 06/2022 - 01/2020
3	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 06/2011
3	Sulfates (Sulfates, Inorganic)IBA 01/2015 - 01/2005
3	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 06/2012 - 03/2007
3	Progesterone Receptors (Progesterone Receptor)IBA 10/2011 - 02/2009
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 02/2009
2	CytokinesIBA 12/2021 - 01/2021
2	Biological FactorsIBA 12/2021 - 09/2015
2	NF-kappa B (NF-kB)IBA 12/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 05/2021 - 03/2006
2	CholesterolIBA 01/2021 - 01/2021
2	CarcinogensIBA 10/2020 - 01/2002
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2017
2	3' Untranslated Regions (3' UTR)IBA 01/2016 - 03/2011
2	Type 1 Melanocortin ReceptorIBA 06/2015 - 09/2006
2	Aurora Kinase AIBA 01/2015 - 07/2007
2	Oral ContraceptivesIBA 06/2014 - 07/2013
2	Insulin-Like PeptidesIBA 08/2012 - 01/2009
2	Environmental CarcinogensIBA 09/2011 - 09/2004
2	Tamoxifen FDA LinkGeneric 01/2010 - 09/2008
2	Catechol EstrogensIBA 01/2009 - 03/2007
2	Glutathione (Reduced Glutathione)IBA 04/2007 - 09/2004
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 03/2007 - 09/2006
1	Alkaline PhosphataseIBA 12/2023
1	IceIBA 01/2023
1	Kazal Pancreatic Trypsin InhibitorIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 08/2022
1	methylglyoxal bis(butylamidinohydrazone)IBA 05/2022
1	Blood Proteins (Serum Proteins)IBA 05/2022
1	TabletsIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	InterleukinsIBA 12/2021
1	Racemases and Epimerases (Epimerases and Racemases)IBA 12/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2021
1	Hematoxylin (Haematoxylon)IBA 07/2021
1	oxidized low density lipoproteinIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021

Therapy/Procedure

12	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 09/2010
12	Salpingo-oophorectomy 08/2020 - 03/2006
11	Therapeutics 12/2023 - 09/2002
6	Ovariectomy (Oophorectomy) 12/2007 - 05/2002
5	Drug Therapy (Chemotherapy) 10/2020 - 08/2005
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2009 - 11/2005
3	Radiotherapy 01/2022 - 06/2006
3	Treatment Delay 01/2022 - 01/2019
3	Adjuvant Chemotherapy 10/2020 - 08/2005
3	Chemoprevention 01/2017 - 01/2002
3	Prophylactic Mastectomy 12/2007 - 05/2002
2	Hysterectomy 01/2023 - 11/2016
2	Castration 01/2021 - 07/2019
2	Aftercare (After-Treatment) 01/2020 - 06/2012
2	Mastectomy (Mammectomy) 11/2014 - 09/2010
2	Estrogen Replacement Therapy 10/2006 - 09/2006
1	Continuity of Patient Care 06/2022
1	Lasers (Laser) 05/2022
1	Palliative Care (Palliative Therapy) 01/2022